The problem with supplementing in the dark

Picture the scene: a bathroom shelf lined with amber bottles — vitamin D, magnesium, omega-3, a B-complex, maybe a collagen powder — each chosen because a podcast said so, or because the label promised energy, or because turning forty seemed like the moment to start taking this seriously. The intention is sound. The question nobody asks is whether any of it is actually needed.

This is the quiet problem at the heart of modern supplement culture. Most adults dose according to category — age bracket, gender, general lifestyle — rather than individual biology. The result, as Professor Paul Lee puts it in Practical Regeneration (2026), is a habit he calls 'Too Much, Too Blind': well-meaning but unanchored, expensive at best and counterproductive at worst.

Professor Lee's framework positions Chemistry — nutrition, hormones, the body's internal environment — as one of four interdependent pillars of regeneration. His argument is direct: chemistry-pillar work starts with assessment, not assumption. Conventional proxies such as BMI or age-based reference ranges tell you where the population average sits. They say almost nothing about what is happening inside a specific body on a specific day. Two people of identical age, weight, and lifestyle can have profoundly different inflammatory loads, hormone profiles, and micronutrient stores — and therefore profoundly different supplementation needs.

The central question this article answers is a practical one: how do you actually know what your body needs, rather than what the category suggests it might?

What biomarkers can and cannot tell you

Blood is extraordinarily talkative — if you know what to ask. A 2024 narrative review by Pokushalov et al. (PMC11643751), cited 36 times in its first year of publication, maps six categories of biomarkers to specific supplementation decisions: genomic, proteomic, metabolomic, lipidomic, microbiome, and immunological. Together they reveal not what someone is eating but what the body is actually doing with what it receives — a fundamentally different question.

The clearest illustration is the MTHFR gene variant. Carried by a substantial proportion of the population, it impairs the conversion of standard folic acid into its active methylated form. Someone with this polymorphism may supplement faithfully for years while their folate metabolism remains partially compromised — invisible on a food diary, visible on a genomic panel. Closely related is homocysteine, a metabolite that rises when B6, B12, or folate is insufficient. Elevated homocysteine is simultaneously a marker of B-vitamin inadequacy and a recognised cardiovascular risk signal; a single venous blood draw captures both at once. Neither requires specialist or research-grade testing — both are available through mainstream UK venous panels today.

The broader principle is the one that sits at the heart of the Chemistry pillar in Regeneration by Design: optimising the body's internal environment demands reading that environment directly. Two people on identical diets can arrive at very different biochemical states because absorption, genetics, inflammatory load, and a dozen other variables all intervene between intake and cellular availability. Dietary recall and population reference ranges cannot see any of that.

One honest caveat: most of the intervention research underpinning this field has been conducted in clinically deficient or unwell populations, and the evidence base for healthy adults in a performance-focused wellness context is still maturing.

Three markers that show why one size never fits all

Vitamin D is the entry point, precisely because it feels so familiar — yet is so routinely mis-dosed. The optimal serum level for immune and musculoskeletal health sits between 75 and 150 nmol/L, well above the threshold the NHS treats as adequate. The difficulty is that individual response to supplementation varies substantially with BMI, skin tone, fat absorption, and genetic variants affecting vitamin D receptor function. A blanket 10 µg per day — the standard population recommendation — may be sufficient for some adults and meaningfully insufficient for others. Without a baseline measurement and a follow-up draw to confirm repletion, it is impossible to know which applies.

Ferritin introduces a categorically different kind of risk: not under-dosing, but causing harm. Ferritin below 30 µg/L signals depleted iron reserves; below 15 µg/L is highly specific for absolute deficiency. But persistently elevated ferritin — above 200 µg/L — frequently reflects systemic inflammation rather than iron adequacy. Someone presenting with fatigue who self-treats with high-dose iron supplements, without testing, may be compounding an inflammatory state rather than resolving a true deficiency. The label on the bottle cannot resolve that distinction; only the blood panel can.

Omega-3 completes the picture by connecting biomarker status directly to biological ageing. In animal models, elevated tissue levels of n-3 fatty acids were associated with leukocyte telomeres 25% longer than in controls at ten months, alongside preserved levels of the shelterin proteins TRF1 (+27%) and TRF2 (+47%), which protect telomere structure from attrition. Whether this translates directly to humans remains to be established. The practical implication, though, is clear: omega-3 status is worth monitoring rather than assuming. An omega-3 index blood test — available through standard panels — indicates whether tissue levels fall within the range associated with these effects, and gives a concrete basis for adjusting oily-fish intake or supplementation dose. Without that reading, a generic capsule dose is another guess.

Three markers, three distinct failure modes: insufficient dosing, active harm, and a missed opportunity to act on the body's own regenerative signals. Assessment before intervention — that is the Chemistry pillar made practical.

How the Regen PhD Blood Panel works as a regeneration map

The design logic of the Regen PhD Blood Panel starts with a question that standard testing never asks: not 'are you ill?' but 'how well is your biology actually functioning?' That distinction shapes all 32 of the markers it measures across six systems — inflammation, metabolic, hormonal, cellular energy, cardiovascular, and liver and detox function.

Conventional NHS screens are calibrated to detect disease. They flag values outside clinical reference ranges; within those ranges, everything comes back as normal. A regeneration map operates differently — it looks for the gap between clinically fine and genuinely optimal: the sub-clinical insulin resistance that has not yet become type 2 diabetes, the inflammatory load quietly suppressing recovery, the cardiovascular risk accumulating in particles a standard cholesterol test does not see.

Three markers illustrate why the panel extends beyond conventional screens. ApoB and Lp(a) measure atherogenic lipoprotein particle number and quality rather than total cholesterol or LDL — an approach that cardiovascular research increasingly identifies as the more accurate predictor of coronary risk. HOMA-IR quantifies insulin resistance directly, identifying a metabolic state that may be present for years before glucose readings raise clinical concern. And hs-CRP — high-sensitivity C-reactive protein — detects low-grade systemic inflammation that falls well below the threshold flagged by standard markers, yet is sufficient to blunt tissue recovery and energy metabolism. Each has a defined, actionable range; each is typically absent from an NHS request form.

Blood is drawn at Harley Street and reviewed by a physician within five working days. That review converts raw numbers into ranked priorities — which systems are performing well, which are under-optimised, and where supplementation or lifestyle adjustment is most warranted. A 2025 MDPI study supports the underlying logic: personalised biomarker-based supplementation was associated with meaningfully reduced inflammatory marker load compared with generic approaches, indicating that acting on what the blood actually shows produces a measurably different outcome.

Serum tests versus intracellular panels: what the difference means in practice

All the panels described above measure nutrients circulating in the bloodstream at the moment blood is drawn — serum testing, in standard terminology. That snapshot is genuinely useful: it is where deficiencies first become visible, where trends can be tracked with repeat draws, and where the Regen PhD Blood Panel operates. But serum concentrations tell only part of the story.

Intracellular, or functional, panels go a layer deeper. Rather than capturing a single moment in the blood, they reflect how nutrients are actually working inside the cell — averaged over the preceding four to six months. A serum B12 reading can appear within range while cellular uptake remains impaired; an intracellular panel catches the gap that the serum draw misses. For most readers, a well-designed serum panel is both the right entry point and the most actionable output. Intracellular testing adds a more granular layer for those who have already addressed obvious deficiencies and want a fuller functional picture.

The evidence base is actively expanding. The Dietary Biomarkers Development Consortium (DBDC, 2025) is using metabolomics and controlled feeding trials to validate next-generation biomarkers — aiming to distinguish, for instance, whether a given nutrient is genuinely reaching the tissues that need it, rather than circulating without being absorbed at the cellular level. Panels of this kind will become more accessible as that science matures.

Genetic context, such as MTHFR variants that limit standard folate processing, can sharpen interpretation once baseline serum data is in hand. Professor Lee's position is that optimising the internal biological environment matters more than fixating on the genetic code — and the blood panel is where that environment becomes legible.

What to do with your results — and what to hold lightly

Getting results back is not the end of the process — it is the moment it begins. A panel does not issue a prescription; it shows, in quantifiable terms, where the internal environment needs support and where it does not. That distinction shapes how to act: some findings warrant confident, immediate adjustment; others belong in the 'watch and retest' column rather than the supplement trolley.

Act with confidence on clear signals. Low serum vitamin D (below 75 nmol/L), elevated homocysteine, suboptimal ferritin, and raised hs-CRP all have well-supported supplement responses — methylated B-vitamins for homocysteine, weight-adjusted vitamin D3 with magnesium, iron only where ferritin confirms depletion rather than inflammation, omega-3s where hs-CRP is persistently elevated. The mechanisms are understood; the therapeutic directions are consistent across the literature.

Hold lightly where the evidence thins. AI-driven interpretation tools, increasingly bundled with premium panels, are not yet sufficiently validated at scale — their outputs are useful prompts, not clinical verdicts. Long-term efficacy data for biomarker-guided supplementation in healthy adults remain sparse; most intervention research has been conducted in clinically deficient or diseased populations, not in people who are broadly well and seeking to optimise. High-dose supplement combinations occupy a regulatory grey area; professional review is worthwhile for anything beyond foundational nutrients. Where results look pathological — very high ferritin, severely depressed hormones, consistently elevated inflammatory load — a conversation with a GP or specialist is the right next step before adjusting anything.

Retesting closes the loop. Practical Regeneration frames monitoring and iteration as a discipline, not a one-off act; a retest three to six months after making changes confirms whether vitamin D has reached the optimal band, whether homocysteine has corrected, whether the protocol holds.

Chemistry answers one question: what does your internal environment actually need right now? But movement load shapes hormonal and inflammatory balance; gut integrity determines how efficiently nutrients absorb; sleep depth governs the repair cycles that give supplementation something to work with. Professor Paul Lee's argument in Regeneration by Design is that these variables are genuinely interdependent — and that knowing your chemistry precisely, through a panel rather than a guess, is how you begin acting on all of them with real intention.

1. [1] Nutritional genomics (Nutrigenomics). https://en.wikipedia.org/?curid=1843196 https://en.wikipedia.org/?curid=1843196